M2 and Signal Labs Launch Transition Intelligence™ Through New Strategic Alliance
New AI-enabled offering extends executive search beyond placement, equipping newly appointed healthcare leaders with
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
M2, the healthcare-focused executive search, board advisory, and leadership intelligence firm formerly known as MercerMorgan, and Signal Labs, the AI-powered attention-infrastructure platform, today announced a strategic alliance and the launch of Transition Intelligence™. The new offering is designed to support newly placed executives through the most consequential window of their tenure: the first 100 days.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260825795764/en/
The alliance pairs M2’s 25-plus years of healthcare leadership advisory, more than 2,000+ executive placements and a network of over 200,000+ healthcare leaders, with Signal Labs’ new category known as Systems of Attention. Together, the firms will deliver leaders a continuously updated view of their new market: competitive dynamics, stakeholder landscape, and strategic priorities that determine how quickly a new executive begins creating value for their company.
The launch follows M2’s recent evolution from MercerMorgan. The rebrand reflects a conviction that the traditional definition of executive search is no longer sufficient on its own. Finding the right leader remains critical. Yet leadership outcomes are increasingly defined by what happens next: how quickly a new executive understands the market, identifies what deserves attention, and begins delivering.
“Companies don’t invest in executive search. They invest in leadership outcomes. Our responsibility doesn’t end when a leader is hired — that’s where the next phase begins. Transition Intelligence is that conviction made operational. Available to M2 search clients, it gives newly placed leaders access to a world-class intelligence infrastructure designed to sharpen decision-making, accelerate impact, and create value from day one.”
-Sal DiGiuseppi, Chief Executive Officer of M2
“Enterprises have an attention problem, and it’s never more acute than in a leadership transition. Transition Intelligence gives one leader the attention infrastructure of an entire enterprise. It’s the first product that treats a leader’s first hundred days as an intuitive system rather than a genre of advice.”
-Rajeev Ronanki, Chief Executive Officer of Signal Labs
Both companies will be at the upcoming Health Evolution on September 27–29, 2026 with executive briefings from both teams, plus live Signal Roadmaps generated on the spot for attending CEOs, board directors, and investors. Learn more at https://www.signallabs.ai/partners-m2.
ABOUT SIGNAL LABS
Signal Labs builds Attention Infrastructure within the new category of Systems of Attention, to help companies across all industries make more effective and defensible decisions across the enterprise. Backed by Lightspeed Venture Partners, Signal Labs identifies which signals deserve attention, routes them to the right leaders in time to act and captures every decision in institutional memory. Learn more at Signal Labs.
ABOUT M2
M2 is a healthcare-focused executive search, board advisory, and leadership intelligence firm built for the next era of leadership. For more than 25 years, the firm has advised boards, CEOs, and investors on the leadership decisions that shape enterprise value. Today, M2 combines deep sector expertise and proprietary market intelligence with AI-enabled capabilities to identify exceptional leaders and accelerate their impact from day one. Learn more at M2MercerMorgan.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260825795764/en/
Media gallery
